Department of Medicine, University of California, San Diego, La Jolla, California 92037, USA.
J Biol Chem. 2011 Sep 23;286(38):33125-33. doi: 10.1074/jbc.M111.218693. Epub 2011 Jul 27.
Neurotransmitter release by catecholaminergic cells is negatively regulated by prohormone cleavage products formed from plasmin-mediated proteolysis. Here, we investigated the expression and subcellular localization of Plg-R(KT), a novel plasminogen receptor, and its role in catecholaminergic cell plasminogen activation and regulation of catecholamine release. Prominent staining with anti-Plg-R(KT) mAb was observed in adrenal medullary chromaffin cells in murine and human tissue. In Western blotting, Plg-R(KT) was highly expressed in bovine adrenomedullary chromaffin cells, human pheochromocytoma tissue, PC12 pheochromocytoma cells, and murine hippocampus. Expression of Plg-R(KT) fused in-frame to GFP resulted in targeting of the GFP signal to the cell membrane. Phase partitioning, co-immunoprecipitation with urokinase-type plasminogen activator receptor (uPAR), and FACS analysis with antibody directed against the C terminus of Plg-R(KT) were consistent with Plg-R(KT) being an integral plasma membrane protein on the surface of catecholaminergic cells. Cells stably overexpressing Plg-R(KT) exhibited substantial enhancement of plasminogen activation, and antibody blockade of non-transfected PC12 cells suppressed plasminogen activation. In functional secretion assays, nicotine-evoked [(3)H]norepinephrine release from cells overexpressing Plg-R(KT) was markedly decreased (by 51 ± 2%, p < 0.001) when compared with control transfected cells, and antibody blockade increased [(3)H]norepinephrine release from non-transfected PC12 cells. In summary, Plg-R(KT) is present on the surface of catecholaminergic cells and functions to stimulate plasminogen activation and modulate catecholamine release. Plg-R(KT) thus represents a new mechanism and novel control point for regulating the interface between plasminogen activation and neurosecretory cell function.
儿茶酚胺能细胞的神经递质释放受由纤溶酶介导的蛋白水解形成的前激素裂解产物负调控。在这里,我们研究了新型纤溶酶原受体 Plg-R(KT)的表达和亚细胞定位及其在儿茶酚胺能细胞纤溶酶原激活和儿茶酚胺释放调节中的作用。在鼠和人组织的肾上腺髓质嗜铬细胞中,用抗 Plg-R(KT)单克隆抗体观察到明显的染色。在 Western blot 中,Plg-R(KT)在牛肾上腺髓质嗜铬细胞、人嗜铬细胞瘤组织、PC12 嗜铬细胞瘤细胞和鼠海马中高度表达。与 GFP 融合的 Plg-R(KT)的表达导致 GFP 信号靶向细胞膜。与尿激酶型纤溶酶原激活物受体(uPAR)的相分离共沉淀和针对 Plg-R(KT)C 端的抗体 FACS 分析一致表明 Plg-R(KT)是儿茶酚胺能细胞表面的完整质膜蛋白。稳定过表达 Plg-R(KT)的细胞表现出纤溶酶原激活的显著增强,而非转染的 PC12 细胞的抗体阻断抑制了纤溶酶原激活。在功能分泌测定中,与对照转染细胞相比,过表达 Plg-R(KT)的细胞中尼古丁诱导的[3H]去甲肾上腺素释放显著减少(减少 51±2%,p<0.001),而非转染的 PC12 细胞的抗体阻断增加了[3H]去甲肾上腺素释放。总之,Plg-R(KT)存在于儿茶酚胺能细胞的表面,作用是刺激纤溶酶原激活并调节儿茶酚胺释放。因此,Plg-R(KT)代表了一种新的机制和新的控制点,用于调节纤溶酶原激活和神经分泌细胞功能之间的界面。